speb/financial-data huggingface dataset:
ZENA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -7266057.00
ZENA balance_sheet (quarterly, 2025-09-30) — Net PPE: 8998428.00
ZENA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1978599.00
ZENA cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 23243035.00
ZENA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 22134881.00
ZENA balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 341850.00
ZENA balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 17864209.00
ZENA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4365003.00
ZENA income_statement (quarterly, 2025-09-30) — Normalized Income: -12067150.00
ZENA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -9479118.00
ZENA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 6698750.00
ZENA income_statement (quarterly, 2025-09-30) — Operating Income: -4801093.00
ZENA income_statement (quarterly, 2025-09-30) — Operating Revenue: 4345408.00
ZENA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 37981124.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 12883.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -56377175.00
ZENA income_statement (quarterly, 2025-09-30) — Other Gand A: 1964241.00
ZENA income_statement (quarterly, 2025-09-30) — Other Income Expense: -204774.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 13530349.00
ZENA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 837568.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3329785.00
ZENA income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 84438.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Properties: 3679787.00
ZENA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 9270230.00
ZENA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4009669.00
ZENA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 51810000.00
ZENA balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 51810000.00
ZENA balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 5327080.00
ZENA income_statement (quarterly, 2025-09-30) — Pretax Income: -12271924.00
ZENA cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 844812.00
ZENA balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ZENA cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -951650.00
ZENA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1978599.00
ZENA balance_sheet (quarterly, 2025-09-30) — Receivables: 2868645.00
ZENA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5196132.00
ZENA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 426216.00
ZENA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -111681.00
ZENA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -31527867.00
ZENA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 465000.00
ZENA income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1010474.00
ZENA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3439715.00
ZENA balance_sheet (quarterly, 2025-09-30) — Share Issued: 37981124.00
ZENA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 35000.00
ZENA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 41209178.00
ZENA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -29675119.00
ZENA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ZENA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Assets: 78552556.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 72540872.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Debt: 32111536.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 41209178.00
ZENA income_statement (quarterly, 2025-09-30) — Total Expenses: 9146501.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 37343378.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 49608569.00
ZENA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 32001451.00
ZENA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4801093.00
ZENA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -204774.00
ZENA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -204774.00
ZENA balance_sheet (quarterly, 2025-09-30) — Working Capital: 23602060.00
ZENA income_statement (annual, 2025-12-31) — +Operating Expense: 20540402.00
ZENA income_statement (quarterly, 2025-12-31) — +Operating Expense: 10649330.00
ZENA income_statement (annual, 2025-12-31) — +Total Revenue: 12912722.00
ZENA income_statement (quarterly, 2025-12-31) — +Total Revenue: 5189998.00
ZENA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 4166885.00
ZENA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 4166885.00
ZENA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1276018.00
ZENA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1276018.00
ZENA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 110671268.00
ZENA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 110671268.00
ZENA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 368228.00
ZENA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 363014.00
ZENA income_statement (annual, 2025-12-31) — Basic Average Shares: 34183348.00
ZENA income_statement (annual, 2025-12-31) — Basic EPS: -1.32
ZENA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3754075.00
ZENA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 10261144.00
ZENA cash_flow (annual, 2025-12-31) — Capital Expenditure: -10215662.00
ZENA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5010759.00
ZENA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 4200338.00
ZENA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 4200338.00
ZENA balance_sheet (annual, 2025-12-31) — Capital Stock: 68016266.00
ZENA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 68016266.00
ZENA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5980366.00
ZENA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5980366.00
ZENA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15074253.00
ZENA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15074253.00
ZENA balance_sheet (annual, 2025-12-31) — Cash Financial: 5980366.00
ZENA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5980366.00
ZENA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 67462042.00
ZENA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 19862860.00
ZENA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -29315176.00
ZENA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8824602.00
ZENA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -35461668.00
ZENA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -15139753.00
ZENA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -883380.00
ZENA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1303096.00
ZENA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -289593.00
ZENA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 48785.00
ZENA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2520991.00
ZENA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2305748.00
ZENA cash_flow (annual, 2025-12-31) — Change In Receivables: -9730598.00
ZENA cash_flow (quarterly, 2025-12-31) — Change In Receivables: -2301403.00
ZENA cash_flow (annual, 2025-12-31) — Change In Working Capital: -13424562.00
ZENA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -3255270.00
ZENA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -976977.00
ZENA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -100149.00
ZENA cash_flow (annual, 2025-12-31) — Changes In Cash: 2685198.00
ZENA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4101495.00
ZENA balance_sheet (annual, 2025-12-31) — Common Stock: 16206266.00
ZENA balance_sheet (quarterly, 2025-12-31) — Common Stock: 16206266.00
ZENA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 16151451.00
ZENA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 16151451.00
ZENA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
ZENA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ZENA balance_sheet (annual, 2025-12-31) — Construction In Progress: 1708194.00
ZENA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1708194.00
ZENA income_statement (annual, 2025-12-31) — Cost Of Revenue: 17695347.00
ZENA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8160781.00
ZENA balance_sheet (annual, 2025-12-31) — Current Assets: 33210192.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Assets: 33210192.00
ZENA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 921068.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 921068.00
ZENA balance_sheet (annual, 2025-12-31) — Current Debt: 3689457.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Debt: 3689457.00
ZENA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 4610525.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4610525.00
ZENA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1270958.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1270958.00
ZENA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1270958.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1270958.00
ZENA balance_sheet (annual, 2025-12-31) — Current Liabilities: 14955764.00
ZENA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 14955764.00
ZENA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2181760.00
ZENA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1384355.00
ZENA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 2181760.00
ZENA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1384355.00
ZENA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2181760.00
ZENA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1384355.00
ZENA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 2181760.00
ZENA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1384355.00
ZENA income_statement (annual, 2025-12-31) — Diluted Average Shares: 34183348.00
ZENA income_statement (annual, 2025-12-31) — Diluted EPS: -1.32
ZENA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -22214320.00
ZENA income_statement (annual, 2025-12-31) — EBIT: -25340795.00
ZENA income_statement (quarterly, 2025-12-31) — EBIT: -13793880.00
ZENA income_statement (annual, 2025-12-31) — EBITDA: -23159035.00
ZENA income_statement (quarterly, 2025-12-31) — EBITDA: -12409525.00
ZENA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -458907.00
ZENA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -179283.00
ZENA cash_flow (annual, 2025-12-31) — End Cash Position: 5980366.00
ZENA cash_flow (quarterly, 2025-12-31) — End Cash Position: 5980366.00
ZENA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 67462042.00
ZENA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 19862860.00
ZENA balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -606722.00
ZENA balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -606722.00
ZENA cash_flow (annual, 2025-12-31) — Free Cash Flow: -45677330.00
ZENA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -20150512.00
ZENA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -106194.00
ZENA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -238143.00
ZENA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -606722.00
ZENA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -606722.00
ZENA income_statement (annual, 2025-12-31) — General And Administrative Expense: 11392420.00
ZENA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6866226.00
ZENA balance_sheet (annual, 2025-12-31) — Goodwill: 12106307.00
ZENA balance_sheet (quarterly, 2025-12-31) — Goodwill: 12106307.00
ZENA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 29144180.00
ZENA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 29144180.00
ZENA balance_sheet (annual, 2025-12-31) — Gross PPE: 18764309.00
ZENA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 18764309.00
ZENA income_statement (annual, 2025-12-31) — Gross Profit: -4782625.00
ZENA income_statement (quarterly, 2025-12-31) — Gross Profit: -2970783.00
ZENA income_statement (annual, 2025-12-31) — Interest Expense: 19877279.00
ZENA income_statement (quarterly, 2025-12-31) — Interest Expense: 8420440.00
ZENA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 19877279.00
ZENA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 8420440.00
ZENA income_statement (annual, 2025-12-31) — Interest Income: 88426.00
ZENA income_statement (quarterly, 2025-12-31) — Interest Income: 64376.00
ZENA income_statement (annual, 2025-12-31) — Interest Income Non Operating: 88426.00
ZENA income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 64376.00
ZENA balance_sheet (annual, 2025-12-31) — Inventory: 2842794.00
ZENA balance_sheet (quarterly, 2025-12-31) — Inventory: 2842794.00
ZENA balance_sheet (annual, 2025-12-31) — Invested Capital: 33407864.00
ZENA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 33407864.00
ZENA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -29315176.00
ZENA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -8824602.00
ZENA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
ZENA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
ZENA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 65308316.00
ZENA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 65308316.00
ZENA balance_sheet (annual, 2025-12-31) — Leases: 200032.00
ZENA balance_sheet (quarterly, 2025-12-31) — Leases: 200032.00
ZENA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3279270.00
ZENA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3279270.00
ZENA balance_sheet (annual, 2025-12-31) — Long Term Debt: 13566956.00
ZENA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13566956.00
ZENA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 16846226.00
ZENA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 16846226.00
ZENA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 65308316.00
ZENA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 65308316.00
ZENA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1167564.00
ZENA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -423315.00
ZENA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 5451922.00
ZENA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 5451922.00
ZENA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -7604441.00
ZENA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
ZENA balance_sheet (annual, 2025-12-31) — Net Debt: 11276047.00
ZENA balance_sheet (quarterly, 2025-12-31) — Net Debt: 11276047.00
ZENA income_statement (annual, 2025-12-31) — Net Income: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income: -22214320.00
ZENA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -22214320.00
ZENA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -22214320.00
ZENA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -22214320.00
ZENA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -22214320.00
ZENA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -45218074.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -22214320.00
ZENA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -22214320.00
ZENA cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2245754.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -484495.00
ZENA income_statement (annual, 2025-12-31) — Net Interest Income: -19788853.00
ZENA income_statement (quarterly, 2025-12-31) — Net Interest Income: -8356064.00
ZENA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -11499703.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -731483.00
ZENA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 64140752.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 19862860.00
ZENA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 64140752.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 64885001.00
ZENA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -19788853.00
ZENA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8356064.00
ZENA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 4630.00
ZENA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4522081.00
ZENA balance_sheet (annual, 2025-12-31) — Net PPE: 17488291.00
ZENA balance_sheet (quarterly, 2025-12-31) — Net PPE: 17488291.00
ZENA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -7969908.00
ZENA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -4526264.00
ZENA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 38817271.00
ZENA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 38817271.00
ZENA balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 341850.00
ZENA balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 341850.00
ZENA balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 15216049.00
ZENA balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 15216049.00
ZENA income_statement (annual, 2025-12-31) — Normalized EBITDA: -23052841.00
ZENA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -12171382.00
ZENA income_statement (annual, 2025-12-31) — Normalized Income: -45111880.00
ZENA income_statement (quarterly, 2025-12-31) — Normalized Income: -21976177.00
ZENA cash_flow (annual, 2025-12-31) — Operating Cash Flow: -35461668.00
ZENA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -15139753.00
ZENA cash_flow (annual, 2025-12-31) — Operating Gains Losses: 14122.00
ZENA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -10118104.00
ZENA income_statement (annual, 2025-12-31) — Operating Income: -25323027.00
ZENA income_statement (quarterly, 2025-12-31) — Operating Income: -13620113.00
ZENA income_statement (annual, 2025-12-31) — Operating Revenue: 12912722.00
ZENA income_statement (quarterly, 2025-12-31) — Operating Revenue: 5189998.00
ZENA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 48020885.00
ZENA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 48020885.00
ZENA balance_sheet (annual, 2025-12-31) — Other Current Assets: 2030715.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2030715.00
ZENA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 3689457.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 3689457.00
ZENA balance_sheet (annual, 2025-12-31) — Other Equity Interest: -56377175.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -56377175.00
ZENA income_statement (annual, 2025-12-31) — Other Gand A: 8503917.00
ZENA income_statement (quarterly, 2025-12-31) — Other Gand A: 4442723.00
ZENA income_statement (annual, 2025-12-31) — Other Income Expense: -106194.00
ZENA income_statement (quarterly, 2025-12-31) — Other Income Expense: -238143.00
ZENA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 17037873.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 17037873.00
ZENA balance_sheet (annual, 2025-12-31) — Other Inventories: 2842794.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Inventories: 2842794.00
ZENA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 17728355.00
ZENA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 16277069.00
ZENA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4362879.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4362879.00
ZENA income_statement (annual, 2025-12-31) — Other Operating Expenses: 319982.00
ZENA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 0.00
ZENA balance_sheet (annual, 2025-12-31) — Other Properties: 11404161.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Properties: 11404161.00
ZENA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 9093887.00
ZENA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 9093887.00
ZENA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 9074281.00
ZENA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 9074281.00
ZENA balance_sheet (annual, 2025-12-31) — Preferred Stock: 51810000.00
ZENA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 51810000.00
ZENA balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 51810000.00
ZENA balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 51810000.00
ZENA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 9095545.00
ZENA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 9095545.00
ZENA income_statement (annual, 2025-12-31) — Pretax Income: -45218074.00
ZENA income_statement (quarterly, 2025-12-31) — Pretax Income: -22214320.00
ZENA cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3321290.00
ZENA cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
ZENA balance_sheet (annual, 2025-12-31) — Properties: 0.00
ZENA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ZENA cash_flow (annual, 2025-12-31) — Purchase Of Business: -7604441.00
ZENA cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2245754.00
ZENA cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -484495.00
ZENA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -11499703.00
ZENA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -7969908.00
ZENA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -4526264.00
ZENA balance_sheet (annual, 2025-12-31) — Receivables: 4166885.00
ZENA balance_sheet (quarterly, 2025-12-31) — Receivables: 4166885.00
ZENA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 17695347.00
ZENA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 8160781.00
ZENA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2181760.00
ZENA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1384355.00
ZENA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1167564.00
ZENA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -423315.00
ZENA balance_sheet (annual, 2025-12-31) — Retained Earnings: -53742186.00
ZENA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -53742186.00
ZENA income_statement (annual, 2025-12-31) — Salaries And Wages: 2888503.00
ZENA income_statement (quarterly, 2025-12-31) — Salaries And Wages: 2423503.00
ZENA income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 6646240.00
ZENA income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2398749.00
ZENA income_statement (annual, 2025-12-31) — Selling General And Administration: 18038660.00
ZENA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9264975.00
ZENA balance_sheet (annual, 2025-12-31) — Share Issued: 48020885.00
ZENA balance_sheet (quarterly, 2025-12-31) — Share Issued: 48020885.00
ZENA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2888503.00
ZENA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2423503.00
ZENA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 67961451.00
ZENA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 67961451.00
ZENA balance_sheet (annual, 2025-12-31) — Tangible Book Value: -12992729.00
ZENA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -12992729.00
ZENA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ZENA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ZENA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ZENA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ZENA balance_sheet (annual, 2025-12-31) — Total Assets: 99763441.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Assets: 99763441.00
ZENA balance_sheet (annual, 2025-12-31) — Total Capitalization: 81528407.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 81528407.00
ZENA balance_sheet (annual, 2025-12-31) — Total Debt: 21456751.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Debt: 21456751.00
ZENA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 67961451.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 67961451.00
ZENA income_statement (annual, 2025-12-31) — Total Expenses: 38235749.00
ZENA income_statement (quarterly, 2025-12-31) — Total Expenses: 18810111.00
ZENA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 31801990.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 31801990.00
ZENA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 66553249.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 66553249.00
ZENA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16846226.00
ZENA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16846226.00
ZENA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -25323027.00
ZENA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -13620113.00
ZENA income_statement (annual, 2025-12-31) — Total Unusual Items: -106194.00
ZENA income_statement (quarterly, 2025-12-31) — Total Unusual Items: -238143.00
ZENA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -106194.00
ZENA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -238143.00
ZENA balance_sheet (annual, 2025-12-31) — Working Capital: 18254428.00
ZENA balance_sheet (quarterly, 2025-12-31) — Working Capital: 18254428.00
ZENA income_statement (quarterly, 2026-03-31) — +Operating Expense: 19435888.00
ZENA income_statement (quarterly, 2026-03-31) — +Total Revenue: 8402319.00
ZENA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4552028.00
ZENA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1843974.00
ZENA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 177444912.00
ZENA cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 203605.00
ZENA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 53774981.00
ZENA income_statement (quarterly, 2026-03-31) — Basic EPS: -0.50
ZENA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5980366.00
ZENA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2397720.00
ZENA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5801899.00
ZENA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 110389252.00
ZENA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 8526481.00
ZENA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 14964566.00
ZENA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 8526481.00
ZENA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 22725705.00
ZENA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -304758.00
ZENA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -18848583.00
ZENA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -2401812.00
ZENA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -128422.00
ZENA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -503183.00
ZENA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4507271.00
ZENA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -7540688.00
ZENA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -588748.00
ZENA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3572364.00
ZENA balance_sheet (quarterly, 2026-03-31) — Common Stock: 24079252.00
ZENA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -3111493.00
ZENA cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 12791189.00
ZENA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2452793.00
ZENA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10535592.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Assets: 38625134.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1198484.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Debt: 3440755.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4639239.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1142536.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1142536.00
ZENA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 14646181.00
ZENA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1375487.00
ZENA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1375487.00
ZENA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1375487.00
ZENA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1375487.00
ZENA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 53774981.00
ZENA income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.50
ZENA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — EBIT: -21466505.00
ZENA income_statement (quarterly, 2026-03-31) — EBITDA: -20091018.00
ZENA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1026249.00
ZENA cash_flow (quarterly, 2026-03-31) — End Cash Position: 8526481.00
ZENA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 22725705.00
ZENA balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -1263101.00
ZENA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -21246303.00
ZENA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 4333296.00
ZENA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 88767.00
ZENA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1263101.00
ZENA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 14070815.00
ZENA balance_sheet (quarterly, 2026-03-31) — Goodwill: 12106307.00
ZENA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 29843098.00
ZENA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22245385.00
ZENA income_statement (quarterly, 2026-03-31) — Gross Profit: -2133273.00
ZENA income_statement (quarterly, 2026-03-31) — Interest Expense: 5083400.00
ZENA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5083400.00
ZENA income_statement (quarterly, 2026-03-31) — Interest Income: 13889.00
ZENA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 13889.00
ZENA balance_sheet (quarterly, 2026-03-31) — Inventory: 2500151.00
ZENA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7403257.00
ZENA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -304758.00
ZENA cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 12791189.00
ZENA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 11098010.00
ZENA balance_sheet (quarterly, 2026-03-31) — Leases: 299311.00
ZENA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 4603415.00
ZENA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7073995.00
ZENA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 11677410.00
ZENA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1163494.00
ZENA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 5864401.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 12791189.00
ZENA balance_sheet (quarterly, 2026-03-31) — Net Debt: 1988269.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -26549905.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -26549905.00
ZENA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -26549905.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -1124120.00
ZENA income_statement (quarterly, 2026-03-31) — Net Interest Income: -5069511.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 1964962.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 9934516.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1163494.00
ZENA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5069511.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 128000.00
ZENA balance_sheet (quarterly, 2026-03-31) — Net PPE: 20401411.00
ZENA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1273600.00
ZENA cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 11098010.00
ZENA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 53355409.00
ZENA balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 341850.00
ZENA balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 16037481.00
ZENA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -20179785.00
ZENA income_statement (quarterly, 2026-03-31) — Normalized Income: -26638672.00
ZENA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -18848583.00
ZENA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 4349477.00
ZENA income_statement (quarterly, 2026-03-31) — Operating Income: -21569161.00
ZENA income_statement (quarterly, 2026-03-31) — Operating Revenue: 8402319.00
ZENA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 61764175.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4415752.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 3440755.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -123080465.00
ZENA income_statement (quarterly, 2026-03-31) — Other Gand A: 5196564.00
ZENA income_statement (quarterly, 2026-03-31) — Other Income Expense: 88767.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 17736791.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Inventories: 2500151.00
ZENA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 439190.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 4273124.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Properties: 13628880.00
ZENA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 6438085.00
ZENA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 8864406.00
ZENA balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 86310000.00
ZENA balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 86310000.00
ZENA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 12192637.00
ZENA income_statement (quarterly, 2026-03-31) — Pretax Income: -26549905.00
ZENA cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
ZENA balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ZENA cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
ZENA cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1124120.00
ZENA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1273600.00
ZENA balance_sheet (quarterly, 2026-03-31) — Receivables: 4552028.00
ZENA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10535592.00
ZENA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1375487.00
ZENA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1163494.00
ZENA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -80292091.00
ZENA income_statement (quarterly, 2026-03-31) — Salaries And Wages: 8874251.00
ZENA income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3989586.00
ZENA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 18060401.00
ZENA balance_sheet (quarterly, 2026-03-31) — Share Issued: 61764175.00
ZENA cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 11098010.00
ZENA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8874251.00
ZENA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 83198507.00
ZENA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -32954591.00
ZENA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ZENA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Assets: 109522098.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 90272502.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Debt: 16316649.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 83198507.00
ZENA income_statement (quarterly, 2026-03-31) — Total Expenses: 29971480.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 26323591.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 70896964.00
ZENA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 11677410.00
ZENA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -21569161.00
ZENA income_statement (quarterly, 2026-03-31) — Total Unusual Items: 88767.00
ZENA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 88767.00
ZENA balance_sheet (quarterly, 2026-03-31) — Working Capital: 23978953.00
ZENA.OL balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 752000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Change In Inventory: -5777000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Change In Payable: 448000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Change In Prepaid Assets: -253000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Change In Receivables: -2622000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Deferred Tax: 0.00
ZENA.OL income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 140000.00
ZENA.OL balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 752000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -2109000.00
ZENA.OL balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 585000.00
ZENA.OL balance_sheet (annual, 2022-03-31) — Other Receivables: 14739000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Purchase Of Business: -2109000.00
ZENA.OL balance_sheet (annual, 2022-03-31) — Raw Materials: 2756000.00
ZENA.OL cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
ZENA.OL cash_flow (annual, 2022-03-31) — Stock Based Compensation: 2929000.00
ZENA.OL income_statement (annual, 2022-03-31) — Write Off: 9000.00
ZENA.OL income_statement (annual, 2023-03-31) — +Operating Expense: 11843000.00
ZENA.OL income_statement (annual, 2023-03-31) — +Total Revenue: 2772066.57
ZENA.OL balance_sheet (annual, 2023-03-31) — Accounts Payable: 12882000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Accounts Receivable: 11770000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 5441000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 780000.00
ZENA.OL income_statement (annual, 2023-03-31) — Basic Average Shares: 2298833000.00
ZENA.OL income_statement (annual, 2023-03-31) — Basic EPS: -0.01
ZENA.OL cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1153000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Capital Expenditure: -430000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Capital Stock: 64087000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1442000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1442000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Change In Working Capital: -9598000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Changes In Cash: 289000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Common Stock: 64087000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Common Stock Equity: 91652000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Common Stock Issuance: 3966000.00
ZENA.OL income_statement (annual, 2023-03-31) — Cost Of Revenue: 10497000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Current Assets: 34566000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Current Debt: 8697000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 8697000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Current Liabilities: 31158000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Depreciation: 4747000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 4747000.00
ZENA.OL income_statement (annual, 2023-03-31) — Diluted Average Shares: 2298833000.00
ZENA.OL income_statement (annual, 2023-03-31) — Diluted EPS: -0.01
ZENA.OL income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — EBIT: -9446000.00
ZENA.OL income_statement (annual, 2023-03-31) — EBITDA: -4699000.00
ZENA.OL cash_flow (annual, 2023-03-31) — End Cash Position: 1442000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Financing Cash Flow: 16563000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Finished Goods: 857000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Free Cash Flow: -16274000.00
ZENA.OL income_statement (annual, 2023-03-31) — General And Administrative Expense: 8730000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENA.OL income_statement (annual, 2023-03-31) — Gross Profit: -7724933.43
ZENA.OL income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 1969000.00
ZENA.OL income_statement (annual, 2023-03-31) — Interest Expense: 2764000.00
ZENA.OL income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 2764000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Interest Paid Cff: -2192000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Inventory: 6448000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Invested Capital: 125596000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Investing Cash Flow: -430000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 780000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3966000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Issuance Of Debt: 20588000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Long Term Debt: 25247000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 25247000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 20588000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -5799000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Long Term Provisions: 33251000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3966000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Net Debt: 32502000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -6037000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -12827000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -12210000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -12827000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Interest Income: -2764000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 14789000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 14789000.00
ZENA.OL income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -2764000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Net PPE: 227565000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -430000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 91652000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 14231000.00
ZENA.OL income_statement (annual, 2023-03-31) — Normalized EBITDA: 1540000.00
ZENA.OL income_statement (annual, 2023-03-31) — Normalized Income: -9083600.00
ZENA.OL cash_flow (annual, 2023-03-31) — Operating Cash Flow: -15844000.00
ZENA.OL income_statement (annual, 2023-03-31) — Operating Income: -19567933.43
ZENA.OL income_statement (annual, 2023-03-31) — Operating Revenue: 2772066.57
ZENA.OL balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 231030253.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Other Equity Interest: 5329000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3406000.00
ZENA.OL income_statement (annual, 2023-03-31) — Other Operating Expenses: 397000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Other Payable: 9579000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Other Receivables: 14906000.00